Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P0PP
|
||||
Former ID |
DNC000691
|
||||
Drug Name |
GKA1
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [535916] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H24N2O5
|
||||
Canonical SMILES |
CC(C)COC1=CC(=CC(=C1)C(=O)NC2=NC=C(C=C2)C(=O)O)OC(C)C
|
||||
InChI |
1S/C20H24N2O5/c1-12(2)11-26-16-7-15(8-17(9-16)27-13(3)4)19(23)22-18-6-5-14(10-21-18)20(24)25/h5-10,12-13H,11H2,1-4H3,(H,24,25)(H,21,22,23)
|
||||
InChIKey |
RTMFZNZPHCZAFG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glucokinase | Target Info | Activator | [535916] | |
KEGG Pathway | Glycolysis / Gluconeogenesis | ||||
Galactose metabolism | |||||
Starch and sucrose metabolism | |||||
Amino sugar and nucleotide sugar metabolism | |||||
Butirosin and neomycin biosynthesis | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Carbon metabolism | |||||
Insulin signaling pathway | |||||
Insulin secretion | |||||
Prolactin signaling pathway | |||||
Glucagon signaling pathway | |||||
Type II diabetes mellitus | |||||
Maturity onset diabetes of the young | |||||
Central carbon metabolism in cancer | |||||
Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | ||||
HIF-1-alpha transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.